TIXiMED, Inc.

26Score

· 2021· 5 people· $2.2M

Clinical-stage pharmaceutical company developing innovative oral therapies for diabetes and metabolic disorders.

Total Score

Clinical-stage pharmaceutical company developing innovative oral therapies for diabetes and metabolic disorders.

2021founded

Activestatus

5people

$4.8Mraised

$2.2Mthis round

Source

Investor	Location	Types	Portfolio
Helmsley Charitable Trust	-	-	1 company

Please log in to comment

No comments yet. Be the first to comment!

Amount Raised$2.2M

ValuationUnknown

Date AnnouncedMarch 13, 2026

Loading investment round...